A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood ...

Immunome's strong financial position supports ongoing clinical development and potential market entry for key assets. See why ...